好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Infratentorial Cerebral Microbleeds and Incident Dementia: The ARIC-Neurocognitive Study
Cerebrovascular Disease and Interventional Neurology
P11 - Poster Session 11 (8:00 AM-9:00 AM)
13-015

To assess the association of infratentorial cerebral microbleeds (CMBs) and incident dementia

Subcortical CMBs are common in older adults and linked to hypertensive small vessel disease. Infratentorial CMBs are similarly associated with hypertension, but their importance regarding dementia risk is less clear. This study investigates the impact of infratentorial CMBs on incident dementia in the community-based, longitudinal Atherosclerosis Risk in Communities-Neurocognitive Study (ARIC-NCS).

Participants (aged 67-90) without intracerebral hemorrhage or dementia (in 2011-13) were included. CMBs were identified and categorized by location from T2*GRE sequences as follows: subcortical, infratentorial, and lobar CMBs, and superficial siderosis. Incident dementia diagnoses were determined through in-person cognitive testing, informant interviews, and hospital records. Cox proportional-hazards models assessed the association between infratentorial CMB presence (vs absence) and frequency (regardless of other concurrent CMB type), each with incident dementia through 2021. Models adjusted for demographics, vascular risk factors, and other imaging markers of small vessel disease.

Among 1574 participants, 303 had CMBs. 69 of these had at least one infratentorial CMB. The presence of infratentorial compared to no infratentorial CMBs was associated with incident dementia in demographic- and vascular risk factor-adjusted models (HR 1.72 [95% CI 1.16-2.55]) but was attenuated after additional adjustment for white matter hyperintensities (HR 1.45 [95% CI 0.97-2.17]). Compared to those with no infratentorial CMBs, the risk of dementia was nonsignificantly elevated in participants with 1 infratentorial CMB (adjusted HR 1.34 (0.83, 2.14) but significantly elevated in those with ≥2 infratentorial CMBs (HR 2.13 [95% CI 1.10-4.11]), compared to individuals with no infratentorial CMBs .

A greater number of infratentorial CMBs is associated with an increased risk of incident dementia in this community-based cohort. Future studies should evaluate the potential etiology of this association and how infratentorial CMBs in combination with other CMB patterns may alter dementia risk.

Authors/Disclosures
Richard Q. Vuong
PRESENTER
Mr. Vuong has nothing to disclose.
Valerie Morrill Ms. Morrill has nothing to disclose.
Jonathan Graff-Radford, MD, FAAN Dr. Graff-Radford has received personal compensation for serving as an employee of Mayo Clinic. Dr. Graff-Radford has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NINDS/NIH. Dr. Graff-Radford has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. Dr. Graff-Radford has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Open evidence . The institution of Dr. Graff-Radford has received research support from NIH. The institution of Dr. Graff-Radford has received research support from Eisai. The institution of Dr. Graff-Radford has received research support from Cognition therapeutics. Dr. Graff-Radford has received personal compensation in the range of $5,000-$9,999 for serving as a Faculty Member with IMPACT AD .
David S. Knopman, MD, FAAN (Mayo Clinic) Dr. Knopman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for DIAN TU study. The institution of Dr. Knopman has received research support from NIH.
Tom Mosley, PhD Dr. Mosley has nothing to disclose.
Michelle C. Johansen, MD Dr. Johansen has received research support from NINDS/NIA. Dr. Johansen has received research support from American Heart Association.
Keenan Walker, PhD The institution of Dr. Walker has received research support from NIA/NIH.
Clifford R. Jack, Jr., MD (Mayo Clinic) The institution of Dr. Jack has received research support from NIH. The institution of Dr. Jack has received research support from Alexander Family Alzheimer's Disease Research Professorship of the Mayo Clinic.
James R. Pike, MBA Mr. Pike has nothing to disclose.
Andrea L. Schneider, MD, PhD (University of Pennsylvania) Dr. Schneider has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN - Neurology.
Rebecca F. Gottesman, MD, PhD (Johns Hopkins University) The institution of Dr. Gottesman has received research support from NIH.